{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P26718",
      "entity_text" : "NKG2D",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0416" ],
      "CellLine" : [ "cellosaurus:CVCL_2529" ],
      "Organ" : [ "uberon:UBERON:0000468" ],
      "Species" : [ "taxonomy:9606" ],
      "CellType" : [ "cl:CL:0000235" ]
    }
  },
  "verbose_text" : "Combinations of donor derived NK cells with an antibody recognizing a glioblastoma restricted surface antigen or a histone deacetylase inhibitor (HDACi) that induced upregulation of NKG2D ligand expression by GB cells have been shown in preclinical models to overcome immunosuppressive effects of brain tumors.",
  "reading_complete" : "2020-08-04T12:30:42Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T12:27:11Z",
  "trigger" : "expression",
  "evidence" : [ "NKG2D ligand expression" ],
  "pmc_id" : "6868035",
  "score" : 0
}